{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:27:56Z","timestamp":1778034476732,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7392","license":[{"start":{"date-parts":[[2012,3,18]],"date-time":"2012-03-18T00:00:00Z","timestamp":1332028800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1038\/nature10908","type":"journal-article","created":{"date-parts":[[2012,3,18]],"date-time":"2012-03-18T16:28:02Z","timestamp":1332088082000},"page":"110-114","source":"Crossref","is-referenced-by-count":321,"title":["Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF\u2013VEGFR2 signalling"],"prefix":"10.1038","volume":"484","author":[{"given":"Rui","family":"Benedito","sequence":"first","affiliation":[]},{"given":"Susana F.","family":"Rocha","sequence":"additional","affiliation":[]},{"given":"Marina","family":"Woeste","sequence":"additional","affiliation":[]},{"given":"Martin","family":"Zamykal","sequence":"additional","affiliation":[]},{"given":"Freddy","family":"Radtke","sequence":"additional","affiliation":[]},{"given":"Oriol","family":"Casanovas","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Bronislaw","family":"Pytowski","sequence":"additional","affiliation":[]},{"given":"Ralf H.","family":"Adams","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,3,18]]},"reference":[{"key":"BFnature10908_CR1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ceb.2008.12.012","volume":"21","author":"M Lohela","year":"2009","unstructured":"Lohela, M., Bry, M., Tammela, T. & Alitalo, K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr. Opin. Cell Biol. 21, 154\u2013165 (2009)","journal-title":"Curr. Opin. Cell Biol."},{"key":"BFnature10908_CR2","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1073\/pnas.0611177104","volume":"104","author":"S Suchting","year":"2007","unstructured":"Suchting, S. et al. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc. Natl Acad. Sci. USA 104, 3225\u20133230 (2007)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature10908_CR3","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1073\/pnas.0611206104","volume":"104","author":"IB Lobov","year":"2007","unstructured":"Lobov, I. B. et al. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc. Natl Acad. Sci. USA 104, 3219\u20133224 (2007)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature10908_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.devcel.2009.01.015","volume":"16","author":"LK Phng","year":"2009","unstructured":"Phng, L. K. & Gerhardt, H. Angiogenesis: a team effort coordinated by Notch. Dev. Cell 16, 196\u2013208 (2009)","journal-title":"Dev. Cell"},{"key":"BFnature10908_CR5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature07083","volume":"454","author":"T Tammela","year":"2008","unstructured":"Tammela, T. et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454, 656\u2013660 (2008)","journal-title":"Nature"},{"key":"BFnature10908_CR6","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nature05577","volume":"445","author":"AF Siekmann","year":"2007","unstructured":"Siekmann, A. F. & Lawson, N. D. Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 445, 781\u2013784 (2007)","journal-title":"Nature"},{"key":"BFnature10908_CR7","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cell.2009.03.025","volume":"137","author":"R Benedito","year":"2009","unstructured":"Benedito, R. et al. The Notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137, 1124\u20131135 (2009)","journal-title":"Cell"},{"key":"BFnature10908_CR8","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nature05571","volume":"445","author":"M Hellstr\u00f6m","year":"2007","unstructured":"Hellstr\u00f6m, M. et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445, 776\u2013780 (2007)","journal-title":"Nature"},{"key":"BFnature10908_CR9","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/nature05355","volume":"444","author":"I Noguera-Troise","year":"2006","unstructured":"Noguera-Troise, I. et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444, 1032\u20131037 (2006)","journal-title":"Nature"},{"key":"BFnature10908_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/bies.20736","volume":"30","author":"AF Siekmann","year":"2008","unstructured":"Siekmann, A. F., Covassin, L. & Lawson, N. D. Modulation of VEGF signalling output by the Notch pathway. Bioessays 30, 303\u2013313 (2008)","journal-title":"Bioessays"},{"key":"BFnature10908_CR11","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/sj.bjc.6604484","volume":"99","author":"G Thurston","year":"2008","unstructured":"Thurston, G. & Kitajewski, J. VEGF and Delta\u2013Notch: interacting signalling pathways in tumour angiogenesis. Br. J. Cancer 99, 1204\u20131209 (2008)","journal-title":"Br. J. Cancer"},{"key":"BFnature10908_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0012-1606(03)00356-7","volume":"262","author":"JJ Haigh","year":"2003","unstructured":"Haigh, J. J. et al. Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling. Dev. Biol. 262, 225\u2013241 (2003)","journal-title":"Dev. Biol."},{"key":"BFnature10908_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/dvg.20367","volume":"46","author":"S Claxton","year":"2008","unstructured":"Claxton, S. et al. Efficient, inducible Cre-recombinase activation in vascular endothelium. Genesis 46, 74\u201380 (2008)","journal-title":"Genesis"},{"key":"BFnature10908_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature09002","volume":"465","author":"Y Wang","year":"2010","unstructured":"Wang, Y. et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465, 483\u2013486 (2010)","journal-title":"Nature"},{"key":"BFnature10908_CR15","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1084\/jem.20080829","volume":"205","author":"U Koch","year":"2008","unstructured":"Koch, U. et al. Delta-like 4 is the essential, nonredundant ligand for Notch1 during thymic T cell lineage commitment. J. Exp. Med. 205, 2515\u20132523 (2008)","journal-title":"J. Exp. Med."},{"key":"BFnature10908_CR16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/intimm\/dxf030","volume":"14","author":"H Han","year":"2002","unstructured":"Han, H. et al. Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int. Immunol. 14, 637\u2013645 (2002)","journal-title":"Int. Immunol."},{"key":"BFnature10908_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.mvr.2007.06.006","volume":"75","author":"LS Harrington","year":"2008","unstructured":"Harrington, L. S. et al. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Microvasc. Res. 75, 144\u2013154 (2008)","journal-title":"Microvasc. Res."},{"key":"BFnature10908_CR18","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1006\/mvre.2002.2443","volume":"64","author":"KL Taylor","year":"2002","unstructured":"Taylor, K. L., Henderson, A. M. & Hughes, C. C. Notch activation during endothelial cell network formation in vitro targets the basic HLH transcription factor HESR-1 and downregulates VEGFR-2\/KDR expression. Microvasc. Res. 64, 372\u2013383 (2002)","journal-title":"Microvasc. Res."},{"key":"BFnature10908_CR19","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1096\/fj.04-3172fje","volume":"19","author":"RC Sainson","year":"2005","unstructured":"Sainson, R. C. et al. Cell-autonomous notch signaling regulates endothelial cell branching and proliferation during vascular tubulogenesis. FASEB J. 19, 1027\u20131029 (2005)","journal-title":"FASEB J."},{"key":"BFnature10908_CR20","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1242\/dev.039990","volume":"136","author":"BM Hogan","year":"2009","unstructured":"Hogan, B. M. et al. Vegfc\/Flt4 signalling is suppressed by Dll4 in developing zebrafish intersegmental arteries. Development 136, 4001\u20134009 (2009)","journal-title":"Development"},{"key":"BFnature10908_CR21","first-page":"1313","volume":"20","author":"L Zhang","year":"2010","unstructured":"Zhang, L. et al. VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis. Cell Res. 20, 1313\u20131331 (2010)","journal-title":"Cell Res."},{"key":"BFnature10908_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/jnci\/dji003","volume":"97","author":"B Pytowski","year":"2005","unstructured":"Pytowski, B. et al. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J. Natl Cancer Inst. 97, 14\u201321 (2005)","journal-title":"J. Natl Cancer Inst."},{"key":"BFnature10908_CR23","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.1046\/j.1432-1033.2001.02476.x","volume":"268","author":"V Kirkin","year":"2001","unstructured":"Kirkin, V. et al. Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2. Eur. J. Biochem. 268, 5530\u20135540 (2001)","journal-title":"Eur. J. Biochem."},{"key":"BFnature10908_CR24","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/ncb2331","volume":"13","author":"T Tammela","year":"2011","unstructured":"Tammela, T. et al. VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nature Cell Biol. 13, 1202\u20131213 (2011)","journal-title":"Nature Cell Biol."},{"key":"BFnature10908_CR25","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1161\/CIRCRESAHA.109.206326","volume":"106","author":"F Galvagni","year":"2010","unstructured":"Galvagni, F. et al. Endothelial cell adhesion to the extracellular matrix induces c-Src-dependent VEGFR-3 phosphorylation without the activation of the receptor intrinsic kinase activity. Circ. Res. 106, 1839\u20131848 (2010)","journal-title":"Circ. Res."},{"key":"BFnature10908_CR26","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/embor.2011.194","volume":"12","author":"D Stenzel","year":"2011","unstructured":"Stenzel, D. et al. Endothelial basement membrane limits tip cell formation by inducing Dll4\/Notch signalling in vivo. EMBO Rep. 12, 1135\u20131143 (2011)","journal-title":"EMBO Rep."},{"key":"BFnature10908_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1161\/CIRCRESAHA.111.240622","volume":"109","author":"S Estrach","year":"2011","unstructured":"Estrach, S. et al. Laminin-binding integrins induce Dll4 expression and Notch signaling in endothelial cells. Circ. Res. 109, 172\u2013182 (2011)","journal-title":"Circ. Res."},{"key":"BFnature10908_CR28","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","volume":"141","author":"MA Lemmon","year":"2010","unstructured":"Lemmon, M. A. & Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 141, 1117\u20131134 (2010)","journal-title":"Cell"},{"key":"BFnature10908_CR29","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1136\/bjo.2006.113902","volume":"91","author":"A Lux","year":"2007","unstructured":"Lux, A., Llacer, H., Heussen, F. M. & Joussen, A. M. Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions. Br. J. Ophthalmol. 91, 1318\u20131322 (2007)","journal-title":"Br. J. Ophthalmol."},{"key":"BFnature10908_CR30","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/S1470-2045(10)70232-1","volume":"11","author":"AM Jubb","year":"2010","unstructured":"Jubb, A. M. & Harris, A. L. Biomarkers to predict the clinical efficacy of bevacizumab in cancer. Lancet Oncol. 11, 1172\u20131183 (2010)","journal-title":"Lancet Oncol."},{"key":"BFnature10908_CR31","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1101\/gad.1239004","volume":"18","author":"A Duarte","year":"2004","unstructured":"Duarte, A. et al. Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev. 18, 2474\u20132478 (2004)","journal-title":"Genes Dev."},{"key":"BFnature10908_CR32","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S1074-7613(00)80054-0","volume":"10","author":"F Radtke","year":"1999","unstructured":"Radtke, F. et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10, 547\u2013558 (1999)","journal-title":"Immunity"},{"key":"BFnature10908_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bbapap.2003.11.010","volume":"1697","author":"PW Manley","year":"2004","unstructured":"Manley, P. W. et al. Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis. Biochim. Biophys. Acta 1697, 17\u201327 (2004)","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnature10908_CR34","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.1021\/jm020899q","volume":"45","author":"PW Manley","year":"2002","unstructured":"Manley, P. W. et al. Anthranilic acid amides: a novel class of antiangiogenic VEGF receptor kinase inhibitors. J. Med. Chem. 45, 5687\u20135693 (2002)","journal-title":"J. Med. Chem."},{"key":"BFnature10908_CR35","first-page":"5209","volume":"59","author":"M Prewett","year":"1999","unstructured":"Prewett, M. et al. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res. 59, 5209\u20135218 (1999)","journal-title":"Cancer Res."},{"key":"BFnature10908_CR36","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1074\/jbc.M508199200","volume":"281","author":"WC Liang","year":"2006","unstructured":"Liang, W. C. et al. Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF. J. Biol. Chem. 281, 951\u2013961 (2006)","journal-title":"J. Biol. Chem."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature10908.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature10908","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature10908.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:59:04Z","timestamp":1684418344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature10908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,18]]},"references-count":36,"journal-issue":{"issue":"7392","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["BFnature10908"],"URL":"https:\/\/doi.org\/10.1038\/nature10908","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.716748325.792103384","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,18]]}}}